Bibliothèque

A meta-analytic review of the associations between dimensions of religious coping and psychological symptoms during the first wave of the COVID-19 pandemic.

INTRODUCTION: In the first wave of the COVID-19 pandemic, the unknown etiology and treatment of the highly transmissible coronavirus posed considerable threats to public mental health. Many people aro…

Psychopathologie de la Religion et de la Spiritualité Trauma Psychologique Religieux

Cheng, C., & Ying, W. (2023). A meta-analytic review of the associations between dimensions of religious coping and psychological symptoms during the first wave of the COVID-19 pandemic.. Front Psychiatry, 14, 1097598. https://doi.org/10.3389/fpsyt.2023.1097598

01/01/2023 Lire →

What Happens to Those Who Exit Jehovah's Witnesses: An Investigation of the Impact of Shunning.

Shunning and ostracism have severe impacts on individuals' psychological and social well-being. Members of Jehovah's Witnesses are subject to shunning when they do not comply with the stated doctrine …

Trauma Psychologique Religieux Témoins de Jéhovas

Luther, R. (2023). What Happens to Those Who Exit Jehovah's Witnesses: An Investigation of the Impact of Shunning.. Pastoral Psychol, 72(1), 105-120. https://doi.org/10.1007/s11089-022-01051-x

01/01/2023 Lire →

The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.

UNLABELLED: COVID-19 is a new type of trauma that has never been conceptually or empirically analyzed in our discipline. This study aimed to investigate the impact of COVID-19 as traumatic stress on m…

Trauma Psychologique Religieux

Kira, I. A., Shuwiekh, H. A. M., Ashby, J. S., Elwakeel, S. A., Alhuwailah, A., Sous, M. S. F., Baali, S. B. A., Azdaou, C., Oliemat, E. M., & Jamil, H. J. (2023). The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.. Int J Ment Health Addict, 21(1), 51-70. https://doi.org/10.1007/s11469-021-00577-0

01/01/2023 Lire →

Mescaline: The forgotten psychedelic.

INTRODUCTION: Mescaline (3,4,5-trimethoxyphenethylamine) is one of the oldest hallucinogens, with evidence of use dating back 5700 years. Mescaline is a naturally occurring alkaloid found in cacti, ma…

Psychopathologie de la Religion et de la Spiritualité

Vamvakopoulou, I. A., Narine, K. A. D., Campbell, I., Dyck, J. R. B., & Nutt, D. J. (2023). Mescaline: The forgotten psychedelic.. Neuropharmacology, 222, 109294. https://doi.org/10.1016/j.neuropharm.2022.109294

01/01/2023 Lire →

Coercive Control in the Courtroom: the Legal Abuse Scale (LAS).

Intimate partner violence (IPV) survivors seeking safety and justice for themselves and their children through family court and other legal systems may instead encounter their partners' misuse of cour…

Enfance et Adolescence

Gutowski, E. R., & Goodman, L. A. (2023). Coercive Control in the Courtroom: the Legal Abuse Scale (LAS).. J Fam Violence, 38(3), 527-542. https://doi.org/10.1007/s10896-022-00408-3

01/01/2023 Lire →

Multimodal Management of Colorectal Liver Metastases: State of the Art.

Liver is the most common site of colorectal cancer (CRC) metastases. Treatment of CRC liver metastases (CRLM) includes different strategies, prevalently based on the clinical and oncological intent. V…

Thérapies de Conversion

Filoni, E., Musci, V., Di, R. i. t. o. . A., Inchingolo, R., Memeo, R., & Mannavola, F. (2023). Multimodal Management of Colorectal Liver Metastases: State of the Art.. Oncol Rev, 17, 11799. https://doi.org/10.3389/or.2023.11799

01/01/2023 Lire →

Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC.

As stage IIIC non-small cell lung cancer (NSCLC) is not recommended for surgical resection, the survival and prognosis for stage IIIC NSCLC remain poor. More powerful and individualized therapies are …

Thérapies de Conversion

Fu, Y., Duan, W., Xu, R., & Chen, J. (2023). Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC.. Front Immunol, 14, 1268153. https://doi.org/10.3389/fimmu.2023.1268153

01/01/2023 Lire →

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer.

BACKGROUND: Currently, gastric cancer with positive lavage cytology without gross peritoneal dissemination (GC-CY1) is a special type of metastatic form with poor prognosis. Consensus guidelines on tr…

Thérapies de Conversion

Lv, J., Wu, J., Wu, H., Ding, P., Guo, H., Yang, P., Tian, Y., Liu, Y., & Zhao, Q. (2023). Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer.. Front Oncol, 13, 1201928. https://doi.org/10.3389/fonc.2023.1201928

01/01/2023 Lire →

Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma.

BACKGROUND: Most patients with hepatocellular carcinoma (HCC) are not candidates for liver resection. We investigated the clinicopathological characteristics and prognosis of patients with initially u…

Thérapies de Conversion

Yu, B., Zhang, N., Feng, Y., Zhang, Y., Zhang, T., & Wang, L. (2023). Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma.. J Hepatocell Carcinoma, 10, 1709-1721. https://doi.org/10.2147/JHC.S432062

01/01/2023 Lire →

A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.

PURPOSE: The purpose of this study was to investigate the triple-combination therapy of lenvatinib plus sintilimab plus arterially-directed therapy as a conversion therapy for initially unresectable h…

Thérapies de Conversion

Gan, L., Lang, M., Tian, X., Ren, S., Li, G., Liu, Y., Han, R., Zhu, K., Li, H., Wu, Q., Cui, Y., Zhang, W., Fang, F., Li, Q., & Song, T. (2023). A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.. J Hepatocell Carcinoma, 10, 673-686. https://doi.org/10.2147/JHC.S404675

01/01/2023 Lire →

The Current Status of Sociopolitical and Legal Issues Faced by Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning Youth.

BACKGROUND: Adolescents today have unprecedented and uninterrupted access to news and current events through broadcast and social media. Lesbian, gay, bisexual, transgender, queer, and questioning (LG…

Thérapies de Conversion

Ramos, N., Burgess, A., & Ollen, E. (2023). The Current Status of Sociopolitical and Legal Issues Faced by Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning Youth.. Adolesc Psychiatry (Hilversum), 12(3), 180-195. https://doi.org/10.2174/2210676611666211105120645

01/01/2023 Lire →

Sintilimab plus Lenvatinib conversion therapy for intermediate/locally advanced hepatocellular carcinoma: A phase 2 study.

INTRODUCTION: Patients with intermediate or locally advanced hepatocellular carcinoma (HCC) who are not eligible for radical treatment typically have a poor overall prognosis. Treatment strategies tha…

Thérapies de Conversion

Wang, L., Wang, H., Cui, Y., Liu, M., Jin, K., Xu, D., Wang, K., & Xing, B. (2023). Sintilimab plus Lenvatinib conversion therapy for intermediate/locally advanced hepatocellular carcinoma: A phase 2 study.. Front Oncol, 13, 1115109. https://doi.org/10.3389/fonc.2023.1115109

01/01/2023 Lire →